Digital Morphology Solution Predicts Breast Cancer Recurrence
PreciseBreast, an AI-powered digital morphology tool, has a fast turnaround time and is cost-effective compared to gene expression tests.
Category: Breast
Breast
Latest
Breast
Latest
Medicare Extends Coverage of Natera’s Signatera MRD Test to Breast Cancer
Natera's Signatera MRD test has met coverage requirements for adjuvant and recurrence monitoring in patients with breast cancer.
Breast
Latest
Genetic Profiling May Identify Breast Cancer Patients Who Can Omit Radiation Therapy
Breast cancer patients who undergo breast-conserving surgery are recommended to do adjuvant radiation therapy to reduce local recurrence risk.
MicroRNA as Biomarker Can Help Predict Breast Cancer Recurrence
MicroRNA (miRNA) can be used as a biomarker to predict which patients are likely to face breast cancer recurrence and mortality.
Read More
Cancer Diagnoses Continue to Lag During Pandemic
More than two years after the COVID-19 pandemic began, cancer diagnoses continue to lag behind pre-pandemic levels.
Read More
A Next-Gen Liquid Biopsy Detects Signs of Breast Cancer in Early-Stages, USC Study Finds
Scientists found indications that a liquid biopsy could determine whether a patient has breast cancer at its early stage.
Read More
Clinical Practice Guidelines Recommend Genetic Testing for Those with Breast Cancer
Invitae released a study recommending genetic testing for those with breast cancer, and showing how testing improves patient outcomes.
Read More
Scientists Identify Biomarkers in Cells that Spread a Deadly Form of Breast Cancer
Scientists identified key molecular differences between breast cancer cells that cling to an initial tumor & those that form distant tumors.
Read More
The Impact of Breast Cancer Overdiagnosis & Overtreatment
Research questions whether the benefits of breast cancer screening has gradually declined due to cases of overdiagnosis and overtreatment.
Read More
Liquid Biopsy Quickly Detects DNA Markers in Advanced Breast Cancer
A new novel, automated liquid biopsy test can detect the presence of cancer DNA in patients with metastatic breast cancer within five hours.
Read More
How Structural Racism May Cause Breast-Biopsy Delays
Black and Asian women are more likely to experience delays in getting breast biopsies after a mammogram identifies an abnormality.
Read More
ASCO Clinical Practice Guideline Adds BCI to Guide Extended Endocrine Therapy Decisions
The ASCO has expanded the utility of BCI in its guideline: “Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer.”
Read More
DCIS Test Identifies Patients in Need of Intensified Therapy
This study validated the clinical utility of a DCIS test to predict recurrence risk and radiation therapy benefit in certain patients
Read More
Scientists Identify Cancer Biomarkers in Breast Milk
Proteins could one day allow breast cancer screenings to be done via blood test thanks to new biomarkers identified in breast milk.
Read More
Liquid Biopsy Tools Help Detect, Monitor Recurrent Breast Cancer
Liquid biopsy performed on serum samples from breast cancer patients can provide increasingly accurate information on cancer progression.
Read More
AI Software Spots Breast Cancer Metastases in Lymph Nodes
Paige, has launched its Paige Breast Lymph Node, an AI software that helps detect if breast cancer has metastasized to lymph nodes.
Read More
Novel Tool Helps Diagnose Inflammatory Breast Cancer
Prior to the new tool, inflammatory breast cancer lacked a formal, objective medical definition, and diagnosis was often delayed, misdiagnosed, or missed.
Read More
Novel Biomarkers Help Decode Metastatic Breast Cancer
New research has found a connection between aggressive breast cancer cells and the dual CXCR4-CCR7 cell surface protein complexes.
Read More